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Recent years have witnessed the discovery of an unprecedented complexity in innate lymphocyte lineages,
now collectively referred to as innate lymphoid cells (ILCs). ILCs are preferentially located at barrier surfaces
and are important for protection against pathogens and for the maintenance of organ homeostasis. Inappro-
priate activation of ILCs has been linked to the pathogenesis of inflammatory and autoimmune disorders.
Recent evidence suggests that ILCs can be grouped into two separate lineages, cytotoxic ILCs represented
by conventional natural killer (cNK) cells and cytokine-producing helper-like ILCs (i.e., ILC1s, ILC2s, ILC3s).
We will focus here on current work in humans and mice that has identified core transcriptional circuitry
required for the commitment of lymphoid progenitors to the ILC lineage. The striking similarities in transcrip-
tional control of ILC and T cell lineages reveal important insights into the evolution of transcriptional programs
required to protect multicellular organisms against infections and to fortify barrier surfaces.Introduction
The last years have witnessed an unprecedented change in our
understanding of innate lymphocyte lineages. It was previously
believed that innate lymphocytes were represented by a single
lymphoid lineage, namely natural killer (NK) cells, that, in many
aspects, resembles cytotoxic T cells. However, it has become
apparent that additional innate lymphocyte subsets exist that
use transcriptional programs and display functions distinct
from conventional NK (cNK) cells. All innate lymphocytes
including cNK cells are now referred to as ILCs. In addition to
cNK cells, three additional groups of ILCs are now being discrim-
inated, ILC1s, ILC2s, and ILC3s. Strikingly, the transcriptional
and effector programs of the various ILC populations resemble
those of T helper subsets, suggesting that the underlying tran-
scriptional circuitry is evolutionarily more ancient than previously
appreciated (Tanriver and Diefenbach, 2014). Here, we will
discuss our current view of developmental and transcriptional
programs common to all ILC lineages and those required for
specification of distinct ILC populations. These recent data pro-
vide a framework for our current view of two principal ILC line-
ages, cytotoxic or killer ILCs (i.e., cNK cells) and helper-like
ILCs (i.e., ILC1s, ILC2s, ILC3s) (Figure 1). We will put a focus
on recent progress in dissecting the ILC1 lineage and on com-
mon transcriptional programs controlling ILC specification.
Identification of ILC1s: More Than Just NK Cells?
ILC1s have only recently been better characterized and are now
classified as an ILC group distinct of cNK cells that expresses
and requires the transcription factor T-bet for lineage specifica-
tion (Bernink et al., 2013; Daussy et al., 2014; Fuchs et al., 2013;354 Immunity 41, September 18, 2014 ª2014 Elsevier Inc.Klose et al., 2014) (Figure 1; Tables 1, 2, and 3). The identification
of bona fide ILC1s in mice was obscured by the fact that ILC1s
were found to express NK cell receptors such as natural killer
cell p46-related protein (NKp46) and NK1.1, which have served
as an operative definition of NK cells. Early on, Di Santo and col-
leagues noticed that thymic NK cells in mice have a distinct
phenotype; they are less cytotoxic but secrete more interferon-
g (IFN-g) than splenic NK cells do (Table 2) (Vosshenrich et al.,
2006). They proposed that the dichotomy between splenic NK
cells and thymic NK cells in mice might parallel the division of
CD56lo and CD56hi NK cell subsets in human blood (Caligiuri,
2008) (Table 1). Recent data from organ-resident ‘‘NK cells’’ indi-
cated that the population of NKp46+NK1.1+ cells might in fact be
heterogeneous and composed of various ILC lineages (Daussy
et al., 2014; Fuchs et al., 2013; Gordon et al., 2012; Klose
et al., 2014; Vosshenrich et al., 2006). Indeed, liver-resident
NKp46+NK1.1+ cells can be separated into a VLA2 (CD49b)+
population expressing the T-box transcription factors Eomes
and T-bet and into a VLA2TRAIL+IL-7Ralo population that ex-
pressed T-bet, but not Eomes (Daussy et al., 2014; Gordon
et al., 2012; Peng et al., 2013; Takeda et al., 2001). VLA2+TRAIL
cells likely represent cNK cells in that they are cytotoxic, require
Eomes for development, and express class I major histocompat-
ibility complex (MHC)-specific inhibitory receptors (i.e., Ly49 re-
ceptors, NKG2A). VLA2TRAIL+NKp46+NK1.1+ cells did not ex-
press Eomes but strictly required T-bet for their development
(Gordon et al., 2012). It has been controversial whether VLA2
TRAIL+ cells constitute immature cNK cells (Gordon et al.,
2012; Takeda et al., 2005) or a distinct ILC lineage (Daussy
et al., 2014; Peng et al., 2013; Sojka et al., 2014). In the intestine,
Figure 1. Refined Lineage Map for the
Development of ILC Lineages
All lymphoid lineages are the progeny of the CLP.
After the branchpoint with the B and T lineages,
an ILC-restricted progenitor might exist (CILP).
Downstream of the CILP, two main ILC lineages
can be discriminated—killer ILCs and helper-like
ILCs. Killer ILCs are represented by cNK cells and
helper-like ILCs are composed of the various
cytokine-producing ILC subsets (i.e., ILC1s,
ILC2s, ILC3s). Whereas helper-like ILCs express
IL-7Ra and require GATA-3 for differentiation,
killer ILCs do not express IL-7Ra and are normally
represented in GATA-3-deficient mice. All helper-
like ILCs (but not killer ILCs) differentiate from the
Id2+ CHILP. A PLZF+ CHILP population has been
identified that has more restricted differentiation
potential. Whether PLZF CHILP are the pre-
cursors of PLZF+ CHILP remains to be experi-
mentally addressed. CLP, common lymphoid
progenitor; CILP, common ILC progenitor; CHILP,
common helper-like ILC progenitor; NKP, cNK-
restricted progenitor.
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was even more complex because NKp46+ ILC3s were recog-
nized as well (Cella et al., 2009; Cupedo et al., 2009; Luci et al.,
2009; Sanos et al., 2009; Satoh-Takayama et al., 2008). Within
the intraepithelial spaceof the intestine, an ILC1subsetwas iden-
tified that was phenotypically distinct from cNK cells and
required T-bet and nuclear factor, interleukin-3 (IL-3) regulated
(NFIL3, also known as E4BP4) for differentiation (Tables 2 and
3) (Fuchs et al., 2013). Genetic reporter systems for lineage-
defining transcription factors allowed to identify intestinal ILC1s
as an ILC lineage separate from cNK cells (expressing an Eomes
reporter) and NKp46-expressing ILC3s (expressing a Rorc re-
porter). Intestinal ILC1s produced copious amounts of IFN-g in
response to IL-12 and provided innate protection against the
intracellular parasite Toxoplasma gondii (Klose et al., 2014).
Identification of ILC2s
IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), all of
which are epithelial cell-derived cytokines, regulate type 2 innate
immune responses against helminths and pathophysiology of
airway allergens (Koyasu andMoro, 2012). The existence of line-
age-negative innate immune cells producing type 2 cytokines
was first reported by Fort et al. demonstrating that IL-25 admin-
istration induced production of IL-5 and IL-13 in Rag2/ mice
that lack all B and T cells (Fort et al., 2001). It was later shown
that a non-B non-T c-Kit+ FcεR1 (non-mast cell) population,
which appears during the initial stages of helminth infection, is
capable of producing IL-4, IL-5, and IL-13 in response to IL-25
(Fallon et al., 2006; Humphreys et al., 2008; Hurst et al., 2002;
Voehringer et al., 2006). The identity of such innate effector cells
had been obscure until 2010 when natural helper cells (Moro
et al., 2010) and nuocytes (Neill et al., 2010), which are now
known as ILC2s, were identified. ILC2s, which produce large
amounts of IL-5 and IL-13 in response to IL-25 or IL-33, were
identified in mesenteric fat-associated lymphoid clusters
(FALC) in naive mice as natural helper cells (Moro et al., 2010)
and in mesenteric lymph nodes of mice administered with IL-25 or IL-33 as nuocytes (Neill et al., 2010). ILC2s were later
shown to be present in other tissues such as lung, intestinal lam-
ina propria, bone marrow, liver, and skin (Furusawa et al., 2013;
Halim et al., 2012a; Hoyler et al., 2012; Kabata et al., 2013;
McHedlidze et al., 2013; Roediger et al., 2013; Salimi et al.,
2013). In addition to type 2 cytokines, ILC2s produce amphiregu-
lin and support the recovery of epithelial barrier integrity after
tissue damage (Monticelli et al., 2011). Recent studies have iden-
tified a role of ILC2s in the initiation of type 2 adaptive immune
responses through class II MHC and cytokine-mediated activa-
tion of T helper 2 (Th2) cells (Halim et al., 2014; Oliphant et al.,
2014). Another type 2 innate cell population, MPPtype2 induced
by IL-25 administration was also reported in 2010 (Saenz et al.,
2010). MPPtype2 cells, however, differ from ILC2s in that they ex-
press neither IL-7 receptor (IL-7R) nor IL-33R and possess the
potential to differentiate into myeloid cells (Saenz et al., 2013;
Saenz et al., 2010). IL-5 and IL-13 produced by ILC2s are critical
for innate protection against helminth and nematode infections
(Koyasu et al., 2010).
ILC3s: Lymphoid Tissue-Inducer Cells and More
The first ILC subset to be characterized were retinoic acid-
related orphan receptor g t (RORgt)-expressing ILC3 in human
tonsils (Cella et al., 2009; Cupedo et al., 2009) and the lamina
propria of the intestine (in both human and mice) (Cella et al.,
2009; Cupedo et al., 2009; Luci et al., 2009; Sanos et al.,
2009; Satoh-Takayama et al., 2008), a subpopulation of which
expressed cell surface markers also found on NK cells (e.g.,
NKp46, NKG2D, NKp44, or CD56). Intestinal ILC3s require
RORgt for lineage specification and, consequently, mice genet-
ically lacking RORgt have no ILC3s (Table 3). A fetal liver-
derived innate lymphocyte subset, termed lymphoid tissue
(LTi) inducer cells, has been identified in humans and mice
that also depends on RORgt for development (Adachi et al.,
1997; Cupedo et al., 2009; Kurebayashi et al., 2000; Mebius
et al., 1997; Sun et al., 2000). It is now believed that LTi cells
constitute a subpopulation of ILC3s (Cupedo et al., 2009). WhileImmunity 41, September 18, 2014 ª2014 Elsevier Inc. 355
Table 1. Phenotype of Human IFN-g-Producing ILC Populations
CD56 NKp44 CD94 KIR CD103 CD160 VLA1 CD49a VLA2 CD49b CD127
Blood CD56hi NK cells ++ – + low/ – – – + +
Blood CD56lo NK cells + – low/+ + – – – + –
Tonsil intraepithelial ILC1s + + + low/ + + + n.d. –
Intestinal intraepithelial ILC1s +/– + – n.d. + + + n.d. –
Tonsil and intestinal converted ILC3s – – – – – – – – +
n.d., not determined.
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low amounts of CCR6 (Klose et al., 2013). Such CCR6/lo
ILC3s rapidly proliferate after birth, express the transcription
factor T-bet, and could upregulate NKp46 (Figure 1). One signif-
icant finding was that ILC3s express type 17 cytokines such as
IL-22 and IL-17A (Cella et al., 2009; Cupedo et al., 2009; Sanos
et al., 2009; Takatori et al., 2009). IL-22 produced by ILC3s is
absolutely required for immunity to attaching-and-effacing bac-
terial infections such as those with Citrobacter rodentium (Son-
nenberg et al., 2011; Zheng et al., 2008). These lines of findings
have revealed unprecedented complexity in innate lymphocyte
lineages. In the following, we will first review recent data that
have revealed core transcriptional hubs required for the devel-
opment of various groups of ILCs. Then, we will highlight our
current understanding of the molecular programs controlling
the specification of distinct ILC lineages. Finally, we will discuss
some of the future outstanding questions that are likely to move
the field forward.
Common Developmental Programs for ILC Fate
Given that ILCs and adaptive immune system lymphocytes all
derive from the common lymphoid progenitor (CLP) (Cherrier
et al., 2012; Klose et al., 2014; Moro et al., 2010; Possot et al.,
2011; Yang et al., 2011), the question arose whether an ILC line-
age-restricted progenitor for some or all ILC populations exists
that is downstream of the CLP. The existence of such common
innate lymphoid progenitor (CILP) or ILC progenitor (ILCP) was
predicted becausemice lacking expression of the transcriptional
regulator inhibitor of DNA binding 2 (Id2) lack all ILC lineages,
whereas B and T cell development was largely unperturbed
(Cherrier et al., 2012; Moro et al., 2010; Satoh-Takayama et al.,
2010; Yokota et al., 1999). Id2 is amember of the helix-loop-helix
(HLH) family of proteins that have important functions in immune
cell-fate decisions (Kee, 2009; Murre, 2005). Id2 heterodimerizes
with E proteins that function as transcriptional activators or re-
pressors. Four mammalian E proteins have been characterized
(E2A, HEB, E12, and E47) that bind to specific DNA sequences
called E-box sites. Although Id2 cannot bind to chromatin itself
(due to the lack of a basic HLH domain), it heterodimerizes
with E proteins and sequesters them away from chromatin,
thereby controlling the pool of E proteins available for DNA bind-
ing (Benezra et al., 1990). Id2 is expressed in high amounts in all
ILC lineages (Carotta et al., 2011; Hoyler et al., 2012), whereas
naive T cells and B cells either express only very low amounts
of Id2 or are Id2-negative. Interestingly, B cell lineage specifica-
tion requires the transcription factor early B cell factor 1 (EBF1)
(Lin and Grosschedl, 1995), which is a potent repressor of Id2
(Treiber et al., 2010). Current concepts indicate that repression356 Immunity 41, September 18, 2014 ª2014 Elsevier Inc.of Id2 is required to establish appropriate concentrations of
E2A,which are permissive for the development of B cells (O’Rior-
dan andGrosschedl, 1999). Deletion of EBF1 inB cell progenitors
(late pro-Bcells) led toderepression of Id2 andNotch and reprog-
rammed committed B cell progenitors into ILC and T cells (Ne-
chanitzky et al., 2013). These data suggest that high level Id2
expression is required to establish ILC fate. While Id2 is now
recognized as an important knot within the transcriptional
network establishing ILC fate, the stage-specific and Id2
controlled transcriptional targets required for ILC specification
and/or maintenance are an important goal for future research.
Id2 and ILC Fate
Recently, Id2 reporter mice (Rawlins et al., 2009) were employed
to identify Id2+ lymphoid progenitors in fetal liver and in the bone
marrow of adult mice that were characterized by the expression
of IL-7Ra and intermediate levels of c-Kit and Sca-1. Although
these cells expressed markers also found on the CLP such as
2B4 and CD27, they were distinct from the CLP as they ex-
pressed Id2 and integrin a4b7 (not expressed by CLP) but did
not express Flt3 and CD93 (expressed by CLP). In addition,
LinId2+IL-7Ra+a4b7
+Flt3CD25 cells did not express any of
the lineage-defining transcription factors of ILC populations
(i.e., RORgt, Eomes, T-bet) suggesting that this population is
not specified to any of the ILC lineages (Klose et al., 2014). After
transfer into alymphoid mice or on the clonal level in vitro, a
single LinId2+IL-7Ra+a4b7
+Flt3-CD25- cell had the potential to
differentiate into ILC2s, ILC3s (including CCR6+ LTi-like cells),
and a peculiar non-NK (i.e., EomesT-bet+) ILC1 population.
Thus, on the clonal level, LinId2+IL-7Ra+a4b7
+Flt3CD25 cells
gave rise to all ILC lineages, but not to cNK cells, suggesting that
all cytokine-producing, helper-like ILCs share a common pro-
genitor and that cNK cells branch off earlier from a putative
CILP (Figure 1). Given its restricted helper-like ILC potential,
the Id2+ common progenitor has been dubbed CHILP, common
helper-like ILC progenitor.
Promyelocytic Leukemia Zinc Finger Is Transiently
Expressed in Helper-like ILC Progenitors
Bendelac and colleagues found that ILCs do not express the
transcription factor promyelocytic leukemia zinc finger (PLZF),
which controls the formation of an innate-like program in
CD1d-restricted T cells (also referred to as iNKT cells) (Kovalov-
sky et al., 2008; Savage et al., 2008). However, lineage tracing for
expression of Zbtb16, the gene encoding PLZF, revealed that all
helper-like ILCs were prominently labeled, whereas cNK cells
and LTi cells did not express PLZF during lineage specification
(Constantinides et al., 2014). Accordingly, Zbtb16-deficient
Table 2. Phenotype of Mouse cNK Cells, ILC1s, and other IFN-g-Producing NKp46+ ILCs
NKp46 NK1.1 VLA2 CD49b VLA1 CD49a TRAIL CD160 CD103 CD127 CD69 Ly49
Splenic cNK + + + – – – – subset – +
Liver cNK + + + – – – – – – +
Intestinal LP cNK + + low subset low + n.d. – + +
Salivary Gland NK + + + + + – + – + +
Uterine NK + + – + + – ? low + +
Intraepithelial ILC1s + + + + + + – low + ?
Intestinal LP ILC1s + + – + low + ? + + –
Liver ILC1s + + – + + + – subset + (subset)
Intestinal LP ex-RORgt+ ILC3s + + – + n.d. + n.d. low + –
Thymic NK cells + + low n.d. n.d. n.d. n.d. high + (subset)
n.d., not determined.
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whereas ILC2s and liver ILC1s were mildly reduced (Table 3).
While NKp46+ ILC3s were positive in a Zbtb16 fate map, they
did not require PLZF for differentiation and/or maintenance.
These data suggest that PLZF is not strictly required for ILC
development. Interestingly, within LinIL-7Ra+c-Kit+a4b7
+ cells
in fetal liver and bonemarrow, a population of PLZF+ progenitors
could be discerned. Adoptive transfer experiments and clonal
differentiation assays revealed that PLZF+ LinIL-7Ra+c-Ki-
t+a4b7
+ cells gave rise to ILC1s, ILC2s, and CCR6/lo ILC3s,
but not to cNK cells or CD4+ ILC3s (i.e., LTi cells). The more
restricted differentiation potential of PLZF+ LinIL-7Ra+c-Ki-
t+a4b7
+ cells as compared to the CHILP might be explained by
the fact that only a subpopulation of CHILP expressed PLZF
(Klose et al., 2014), suggesting that PLZF+ CHILP are the prog-
eny of PLZF CHILP and have a more restricted differentiation
potential. Furthermore, clonal analyses showed that only less
than 10% of the PLZF+ progenitor population had potential to
generate three ILC subsets and more than 50% of clones gener-
ated only a single ILC type, raising the possibility that these pro-
genitor populations are amixture of bona fide CHILP and already
committed cells (Constantinides et al., 2014). Future work will
need to reveal how PLZF and Id2 restrict the lymphoid differen-
tiation program to the ILC lineage.
Helper-like ILCs Require the Transcription Factor
GATA-3 for Development
Both of the above reports (Constantinides et al., 2014; Klose
et al., 2014) might indicate that cNK cells develop independently
of CHILP populations, suggesting that NK cell progenitors
branch off earlier during ILC development (Figure 1). Indeed,
cNK cells seem to upregulate Id2 only after lineage specification
because the recently identified refined NK cell progenitor (Fath-
man et al., 2011) is largely Id2 (Klose et al., 2014), which is
consistent with previous reports (Boos et al., 2007). The view
that ILCs might be subdivided into two major lineages (i.e., killer
ILCs and helper-like ILCs) is supported by another set of
data revealing that GATA binding protein-3 (GATA-3) plays
important roles for the development of helper-like ILCs, but
not for that of cNK cells. Genetic deletion of Gata3 in all hemato-
poietic cells resulted in a lack of all IL-7Ra-expressing helper-
like ILCs, whereas the differentiation of cNK cells was largelynormal (Samson et al., 2003; Vosshenrich et al., 2006; Yagi
et al., 2014). Very similar data were obtained using fetal liver
chimeras generated with Gata3-deficient hematopoietic pro-
genitors (Serafini et al., 2014). It is interesting that helper-like
ILCs, but not cytotoxic cNK cells, are Gata3-dependent,
revealing another interesting analogy to T cell lineages. Previous
data demonstrated that deletion of Gata3 in developing T cells
diminished helper T cell development, but not that of cytotoxic
CD8 T cells (Zhu et al., 2004). It should be noted that the roles
of GATA-3 for ILC development and function are complex
and highly stage-specific. Early deletion of Gata3 in all hemato-
poietic cells perturbs development of all helper-like ILC line-
ages, whereas deletion of Gata3 downstream of the CHILP
such as in all Id2-expressing cells or in Ncr1-expressing cells
leads to a selective block in ILC2 (Hoyler et al., 2012; Yagi
et al., 2014) or ILC1 development (Klose et al., 2014), respec-
tively, whereas the differentiation of other ILC subsets was
rather normal (Table 3).
NFIL3, a Central Transcription Factor for All ILCs?
Very recently, the transcription factor NFIL3 (also known as
E4BP4) has been implicated in the differentiation of various
ILC lineages. Previous work had identified NFIL3 to be required
for the differentiation of cNK cells (Gascoyne et al., 2009; Kami-
zono et al., 2009). Now a broader role of NFIL3 for the differen-
tiation of various ILC lineages is becoming apparent (Geiger
et al., 2014; Seillet et al., 2014b). NFIL3-deficient mice have
reduced numbers of ILC2s and ILC3s (including LTi cells), lead-
ing to profound defects in immunity to C. rodentium infection
(requiring IL-22-producing ILC3s) or in papain-induced allergies
(requiring ILC2s) (Seillet et al., 2014b). NFIL3-deficient mice
lacked the CHILP population indicating that Nfil3 might be
already needed for the generation of early ILC progenitors
most likely at the stage of CILP given that both cytotoxic
and helper-like ILC are affected by Nfil3 deficiency (Figure 1;
Table 3). However, this model needs to be revisited in the light
of previous data showing that the NK precursor is unaffected
in Nfil3/ mice and that mice lacking NFIL3 still have lymph
nodes indicating that ILC3 development cannot be entirely
blocked (Gascoyne et al., 2009; Kamizono et al., 2009). Future
studies will need to define on a molecular level how NFIL3 con-
trols or contributes to ILC fate.Immunity 41, September 18, 2014 ª2014 Elsevier Inc. 357
Table 3. Transcription Factors and Cytokines Required for Mouse ILC Development and Survival
Id2 NFIL3
GATA-3
(Vav-Cre or
chimeras)
GATA-3
(Id2-
CreERt2)
GATA-3
(Ncr1-Cre) PLZF Eomes T-bet RORgt IL-7R IL-15
Splenic cNK YYY YYY / n.d. n.d. n.d. YYY / orYY / [[ YY
Liver VLA2+ cNK n.d. YYY n.d. n.d. n.d. / YYY / n.d. / YY
Liver VLA2 ILC1 n.d. /a or YYb n.d. n.d. n.d. YY / YYY n.d. n.d. YY
Intestinal LP cNK n.d. YYY n.d. n.d. / n.d. YYY / / [[ YY
Intestinal LP ILC1 n.d. YYY n.d. n.d. YYY n.d. / YYY / / YY
Intestinal LP ex-
RORgt+ ILC3
n.d. YYY n.d. n.d. / n.d. / YYY YYY YY YY
Intraepithelial ILC1 YYY YYY [[ n.d. n.d. / n.d. YYY / n.d. YY
Uterine VLA2+ cNK n.d. YYY n.d. n.d. n.d. n.d. YYY / n.d. n.d. YY
Uterine VLA2 ILC1 n.d. / n.d. n.d. n.d. n.d. / / n.d. n.d. YY
Salivary gland
NKp46+
n.d. / n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. YY
Thymic NKp46+ / (?) YY YYY n.d. n.d. n.d. n.d. n.d. n.d. YY /
ILC2 (LP, visceral
fat, lung)
YYY YY YYY YYY n.d. YY n.d. n.d. / YY /
Intestinal LP CCR6+
ILC3
YYY YY YYY / n.d. / / / YYY YY /
Intestinal LP
CCR6/lo ILC3
YYY YY YYY / n.d. / / NKp46-/ or
[[ NKp46+ YYY
YYY NKp46- YY
NKp46+ YY
NKp46-/
NKp46+/
n.d., not determined; YYY, population strictly requires factor for development; YY, population is reduced; /, no change in population size; [[,
population is increased.
aSeillet et al. (2014a) and Sojka et al. (2014) have reported virtually normal numbers of liver VLA2- ILC1 in Nfil3/ mice.
bKamizono et al. (2009) and Crotta et al. (2014) have reported reduced of liver VLA2- ILC1 in Nfil3/ mice.
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Notch signals play a complex role in ILC development, and it has
recently become apparent that they are a major common de-
nominator for ILC lineage differentiation. The CHILP gives rise
to ILC1s, ILC2s, and ILC3s in in vitro cultures with OP9 feeder
cells expressing the Notch ligand delta-like 1 (DL1) (OP9-DL1)
(Klose et al., 2014). In line with these findings, ILC1s, as well as
NKp46+ ILC3s, were severely reduced in mice lacking the Notch
signaling adaptor RBP/J (Lee et al., 2012).Moreover, ILC2 devel-
opment in vitro and in vivo required Notch signals (Wong et al.,
2012; Yang et al., 2013). ILC3s also require Notch for develop-
ment, although its necessity seems to differ depending on the
origin of the precursor used (fetal versus adult) (Cherrier et al.,
2012; Possot et al., 2011). It was suggested that ILC3 differenti-
ation is supported by intermittent provision of Notch ligands,
whereas it is hindered in constant presence of Notch signaling,
adding an additional layer of complexity to Notch signaling in
developing ILCs (Cherrier et al., 2012). Beyond the initial devel-
opment, ILC3 differentiation and acquisition of T-bet and
NKp46 requires Notch signals, corroborating the previous find-
ings in RBP/J-deficient animals (Rankin et al., 2013). Notch
signaling drives the development of both ILCs and T cells; how-
ever in humans, the signal strength through Notch regulates the
fate of progenitor cells and directs lineage commitment (Gentek
et al., 2013). Moreover, the Notch signaling pathway probably
differs in ILCs and T cells because Hes-1, a target of the Notch
signaling pathway, is dispensable for ILC2s, but not for T cell dif-
ferentiation (Yang et al., 2013). Downstream of Notch, TCF-1 en-
coded by Tcf7 is induced and directly triggers upregulation of358 Immunity 41, September 18, 2014 ª2014 Elsevier Inc.Il7ra gene expression in ILC2s (Mielke et al., 2013; Yang et al.,
2013). The role of Notch also extends to ILC function because
the Notch-TCF-1 axis positively regulates the expression of re-
ceptors for IL-2, IL-25, and IL-33 through induction of GATA-3
and is required for IL-22 production by ILC3s (Mielke et al.,
2013; Yang et al., 2013). However, spatiotemporal control of
Notch signals for ILC fate is not well understood at the moment.
The work summarized has provided a great deal of information
on transcriptional programs affecting common ILC fate in the
mouse model. Analogous precursors in humans still remain to
be identified.
Differentiation of ILC1s
The general challenge when dealing with ILC1 subsets was their
phenotypic resemblance (e.g., NKp46+, NK1.1+, T-bet+) making
it difficult to discriminate subsets and to assign them to separate
lineages. Only recently, through the use of genetic reporter sys-
tems faithfully reporting the expression of lineage-specifying
transcription factors, some progress has been made in sepa-
rating ILC1 populations from cNK cells. Differentiation of cNK
cells depends on sequential steps controlled by the transcription
factors Id2, NFIL3, and Eomes. The development and mainte-
nance of cNK cells require IL-15 signaling through IL-2Rb
(CD122) and the cytokine receptor common g chain (gc). How-
ever, thymic NK cells develop through a distinct developmental
pathway that involves the transcription factor GATA-3 and
signaling through the IL-7 receptor (CD127), and they produce
IFN-g and granulocyte macrophage colony-stimulating factor
(GM-CSF) in much higher amounts than cNK cells (Ribeiro
et al., 2010; Vosshenrich et al., 2006) (Table 3). IFN-g-producing
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mice (intraepithelial ILC1s) are equipped with a unique set of
integrins and adhesion molecules such as VLA-1, CD160, and
CD103 (in humans), manifest strong transforming growth factor
b (TGF-b) imprinting and do not entirely rely on IL-15 signaling
(Fuchs et al., 2013) (Tables 1 and 2).
The human oral and intestinal mucosa were found to harbor
yet another subset of IFN-g-producing ILCs that express the re-
ceptor for IL-7 and lack NK cell markers and lytic enzymes
(Bernink et al., 2013). These cells were also called ILC1s and
were proposed to arise from the conversion of RORgt+ ILC3s
under the influence of IL-12 during inflammation. Supporting
this, human ILC3s can differentiate into RORgt IFN-g-produc-
ing cells in vitro when cultured in IL-2 (Cella et al., 2010; Hughes
et al., 2010; Hughes et al., 2009). Moreover, fate-mapping exper-
iments using Rorc-Cre mice and ILC3 transfer experiments
showed that some IFN-g-producing ILCs do, indeed, originate
from RORgt+ ILC3s (Klose et al., 2014; Vonarbourg et al.,
2010). Together, these studies have suggested that a certain
percentage of IFN-g-producing ILCs might stem from ILC3s.
Because the development of cNK cells required Eomes, and
T-bet was required for functional maturation and bone-marrow
egress (Gordon et al., 2012; Jenne et al., 2009; Townsend
et al., 2004), attention has focused on these two transcription
factors. Interestingly, TRAIL+VLA-1(CD49a)+VLA-2 liver NK
cells are T-bet and IL-15-dependent, but Eomes-independent
(Daussy et al., 2014; Sojka et al., 2014), consistent with a distinct
developmental pathway. Indeed, TRAIL+VLA-2 liver NK cells
did not express Eomes but strictly required T-bet for their devel-
opment (Daussy et al., 2014; Gordon et al., 2012). Uterine NK
cells are both T-bet and Eomes independent (Sojka et al.,
2014), perhaps reflecting redundancy of these transcription fac-
tors. This might also be the case for salivary gland NK cells,
because they express high amounts of both T-bet and Eomes
(Cortez et al., 2014).
NFIL3 promotes the development of bone-marrow-derived
NK cells from CLP in the steady state (Gascoyne et al., 2009; Ka-
mizono et al., 2009; Male et al., 2012). Recent studies have
shown thatNfil3 is required for the formation of splenic cNK cells,
as well as thymic NK cells, possibly by directly regulating the
expression of downstream transcription factors such as Eomes
and Id2 (Male et al., 2014; Seillet et al., 2014a). In contrast, liver
VLA-2–Eomes– NK cells (Sojka et al., 2014) and salivary gland
VLA-2+Eomes+ NK cells (Cortez et al., 2014) seem to develop
independently of NFIL3. It should be noted, however, that the
impact of NFIL3 seems to be affected by the environment and
might vary due to infection, inflammation, and perhaps housing
conditions. For example, although NFIL3 is required for the
development of conventional NK cells in the steady state,
NFIL3 is dispensable for NK cells that express the MCMV-spe-
cific receptor Ly49H during MCMV infection (Firth et al., 2013).
This variability might explain seemingly contradictory results
regarding the impact of NFIL3 on the development of thymic
NK cells (Crotta et al., 2014; Seillet et al., 2014a) and liver
VLA-1+ NK cells (Sojka et al., 2014). Therefore, dependence on
NFIL3 is most likely insufficient to unequivocally define a cell
lineage (Table 3).
While cNK cells develop from Id2– CLP, intestinal ILC1s and
VLA-1+ liver NK cells develop from Id2+PLZF+ CHILP (Constan-tinides et al., 2014; Klose et al., 2014). Thus, these studies estab-
lish liver VLA-1+ NK cells and intestinal ILC1s as a separate ILC1
lineage, distinct from cNK cells. It will be interesting to see
whether uterine and salivary gland NK cells also arise from
CHILP or are more related to cNK cells. In addition to originating
from discrete precursors, cNK cells and ILC1smight also differ in
the timing and site of development. For example, liver ILC1s
might develop early on during embryogenesis from the fetal liver
and replicate in situ to maintain stable numbers.
Differentiation of ILC2s
Beyond Id2, IL-7, and the cytokine receptor common g chain
(Cao et al., 1995; Moro et al., 2010; Satoh-Takayama et al.,
2010; Yokota et al., 1999), differentiation of ILC2s requires the
transcription factors GATA-3, RORa, and TCF-1, as well as
Notch signaling (Furusawa et al., 2013; Gentek et al., 2013; Hoy-
ler et al., 2012; Klein Wolterink et al., 2013; Mielke et al., 2013;
Moro et al., 2010; Wong et al., 2012; Yang et al., 2013).
GATA-3 has broader roles in ILC development because deletion
of Gata3 in all hematopoietic cells using Vav-Cre (Yagi et al.,
2014) or in fetal liver chimeras (Serafini et al., 2014) revealed
that GATA-3 is critical for the differentiation of all helper-like
ILC subsets, but not for cNK cells. Deletion of the Gata3 gene
at a later time point using Id2CreERt2/+ mice resulted in the
impaired differentiation of ILC2s, but not ILC3s (Hoyler et al.,
2012). Similarly, when Rosa26CreERt2/+ x Gata3flox/flox bone-
marrow cells were transplanted into lethally irradiated mice
and 4-hydroxytamoxifen was administered into the mice 1 day
after the bone-marrow transplantation, differentiation of ILC2s,
but not of ILC3s, was strongly suppressed (Furusawa et al.,
2013; Yagi et al., 2014). Transgenic overexpression of GATA-3
increased ILC2 numbers concomitant with higher expression
of IL-33R (Klein Wolterink et al., 2013). These results suggest
that GATA-3 plays important roles in multiple steps of ILC differ-
entiation and/or survival but high-level GATA-3 expression in
lineage-specified ILC is specifically required for ILC2 mainte-
nance (Table 3). GATA-3 is also required for the differentiation
of human ILC2 (Mjo¨sberg et al., 2012). Future research needs
to provide a molecular understanding of the GATA-3-directed
gene expression networks in the various ILC subsets and in pro-
genitor populations.
RORa, a member of retinoic-acid-receptor-related orphan
nuclear receptor, is highly expressed in ILC2s (Moro et al.,
2010; Wong et al., 2012). ILC2 differentiation was severely
impaired in a natural Rora mutant (Rorasg/sg mouse) without
affecting other ILC subsets (Halim et al., 2012b; Wong et al.,
2012), indicating that RORa is a transcription factor specifically
required for ILC2 differentiation. Small numbers of ILC2 cells
are present in themesentery ofRorasg/sg mice and those residual
cells are able to produce IL-5 and IL-13 in response to IL-33 (Fur-
usawa et al., 2013), indicating that RORa is dispensable for cyto-
kine production induced by IL-33 signals. Unlike RORa, GATA-3
is essential for the expression of IL-5 and IL-13 in mature ILC2s
(Furusawa et al., 2013; Hoyler et al., 2012; Klein Wolterink et al.,
2013; Liang et al., 2012; Yagi et al., 2014).
In addition to factors involved in the differentiation of ILC2s,
other factors play roles in differentiation and functional matura-
tion of ILC2s. Vitamin A and its metabolites derived from food
control the balance between ILC2s and ILC3s in the intestine
as discussed later (Spencer et al., 2014; van de Pavert et al.,Immunity 41, September 18, 2014 ª2014 Elsevier Inc. 359
Immunity
Review2014). Functional specification of ILC2s requires Gfi1 because
the lack of the Gfi1 gene resulted in the loss of GATA-3 expres-
sion and coexpression of IL-13 and IL-17 (Spooner et al., 2013).
Gfi1 directly activated the expression of Il1rl1 and Il17rb genes
encoding receptors for IL-33 and IL-25, respectively. On the
other hand, Gfi1 suppressed the characteristics of ILC3s through
the suppression of the Sox4-Rorc axis required for the expres-
sion of Il17a gene (Spooner et al., 2013). Interestingly, work
with human ILC3s had indicated that they can become pro-
ducers of IL-5 and IL-13 when stimulated with TLR2 ligands
(Crellin et al., 2010a). These results suggest potential plasticity
between ILC2s and ILC3s under certain environmental condi-
tions, which remains to be elucidated. Other outstanding ques-
tions arewhether class II MHC expression is limited to ILC2s (Oli-
phant et al., 2014) and ILC3s (Hepworth et al., 2013) and how
such class II MHC expression fits with our current understanding
of transcriptional regulation of ILCs and of ILCs being part of the
lymphoid branch of hematopoietic cells.
Differentiation of ILC3s
Group 3 ILCs contain various populations of RORgt-expressing
ILCs that play important roles in lymphoid organogenesis and
that are a substantial innate source of ‘‘type 17 cytokines’’
involved in protectingmucosal barriers against extracellular bac-
terial and fungal infections (Diefenbach, 2013). The common de-
nominator of the various ILC3 populations is their dependency
on the transcription factor RORgt, which specifies and defines
the ILC3 lineage. RORgt expression has not been reported in
other ILC lineages. Rorc(gt), an alternative transcript of the
Rorc gene, was initially found to be expressed in all CD4+CD8+
thymocytes, and overexpression of RORgt protected such DP
thymocytes against activation-induced cell death (He et al.,
1998). Surprisingly, genetic deletion of the Rorc gene had a
mild T cell phenotype but these mice lacked all peripheral lymph
nodes and Peyer’s patches (Eberl et al., 2004; Kurebayashi et al.,
2000; Sun et al., 2000). Lack of lymphoid organ development in
RORgt-deficient animals was linked to the absence of LTi cells.
LTi cells were first identified as innate lymphocytes in lymph
node and Peyer’s patch anlagen of E13.5–E15.5 mice (Adachi
et al., 1998; Adachi et al., 1997; Mebius et al., 1997; Yoshida
et al., 2002). Interestingly, a phenotypically related and RORgt-
dependent lymphoid population was found to be required in
the small intestine to coordinate formation of dispersed
lymphoid clusters found in the lamina propria of the intestine
known as cryptopatches and isolated lymphoid follicles (Eberl,
2005; Eberl and Littman, 2004; Hamada et al., 2002; Kanamori
et al., 1996). ILC3s can be differentiated from LinIL-7Ra+
Flt3a4b7
+ fetal liver progenitors that sequentially acquired Id2,
CXCR6, and RORgt expression (Cherrier et al., 2012; Possot
et al., 2011).
Although a role of LTi cells as organizers of lymphoid organ
development is well documented, only recently did it become
clear that they are substantially represented in the intestinal lam-
ina propria of adult micewhere they produce copious amounts of
IL-22 and IL-17A and contribute to immunity to infections and the
pathogenesis of inflammatory diseases (Buonocore et al., 2010;
Cella et al., 2009; Cupedo et al., 2009; Luci et al., 2009; Powell
et al., 2012; Sanos et al., 2009; Satoh-Takayama et al., 2008;
Takatori et al., 2009; Vonarbourg et al., 2010). More recently, it
was shown that ILC3s also produce GM-CSF, which established360 Immunity 41, September 18, 2014 ª2014 Elsevier Inc.important crosstalk with GM-CSF-responsive mononuclear
phagocytes that regulate oral tolerance (Mortha et al., 2014).
These intestinal ‘‘LTi-like cells’’ expressed surface receptors
often found onNK cells such asNKp46, NKp44, andCD56 raised
questions about the relationship between NKp46+ ILC3s and NK
cells. Compelling evidence from fate-map studies has been pro-
vided showing that NKp46+ ILC3s develop independent of the
NK cell lineage and are the progeny of NKp46 ILC3s (Crellin
et al., 2010b; Klose et al., 2014; Satoh-Takayama et al., 2010;
Sawa et al., 2010; Vonarbourg et al., 2010).
The existence of NKp46 and NKp46+ ILC3s raised the ques-
tion of whether these are independent ILC lineages or rather
differentiation or activation products of the same lineage. Two
reports have found that ILC3s can be subdivided into
CCR6+IL-7RahiKithi and CCR6/loIL-7RaloKitlo cells that might
constitute separate ILC3 lineages, both of which require RORgt
for development (Klose et al., 2013; Sawa et al., 2010). It has now
become clear that CCR6+ and CCR6/lo ILC3s follow distinct
transcriptional programs. CCR6hi ILC3 seed the intestine early
during fetal development and seem to be long-lived and slowly
cycling cells (Eberl and Littman, 2004; Hanash et al., 2012;
Sawa et al., 2010). In contrast, CCR6/lo ILC3s account only
for a small fraction of ILC3s at birth but vigorously expand during
the first 4 weeks after birth (Klose et al., 2013). Expansion of
CCR6/lo ILC3 was dependent on the expression of the ligand
activated transcription factor aryl hydrocarbon receptor (AhR).
Mice genetically lacking AhR expression in all cells or in ILC3s
had a largely unaltered compartment of CCR6+ ILC3 whereas
CCR6/lo ILC3s were diminished (Kiss et al., 2011; Klose et al.,
2013; Lee et al., 2012; Qiu et al., 2012). AhR-independent devel-
opment of CCR6+ ILC3s with LTi function was also documented
by the fact that fetally forming lymphoid organs (i.e., lymph
nodes, Peyer’s patches) were normal in AhR-deficient mice.
Curiously, cryptopatches and ILF were absent in AhR-deficient
mice, suggesting that CCR6/lo ILC3s have either nonredundant
LTi function or that AhR regulates crucial LTi effector molecules
in CCR6+ ILC3s. The reduced maintenance of CCR6/lo ILC3 in
AhR-deficient mice might be explained by a role of AhR in regu-
lating expression of the receptor tyrosine kinase c-Kit because
AhR directly bound to the c-Kit promoter and controlled tran-
scription of the Kit gene (Kiss et al., 2011). AhR is a sensor of
various small molecules that confer transcriptional activity to
the AhR (McIntosh et al., 2010). Interestingly, nutrient-derived
AhR ligands such as glucobrassicins contained in vegetables
of the Brassicaceae family (e.g., broccoli, Brussels sprouts)
were recently identified to have an important role in driving post-
natal expansion of CCR6/lo ILC3s (Kiss et al., 2011) and intrae-
pithelial gd T cells (Li et al., 2011), demonstrating a broad role of
plant-derived phytochemicals in controlling development and
maintenance of immune system components at barrier surfaces.
The majority of NKp46CCR6/lo ILC3s coexpressed T-bet
(Klose et al., 2013; Rankin et al., 2013; Sciume´ et al., 2012). While
plastic (‘‘ex-RORgt+’’) ILC3s can be found in humans (Bernink
et al., 2013), it remains to be seen whether T-bet-expressing
CCR6/lo ILC3s exist in humans. Coexpression of T-bet and
RORgt was a remarkable finding because it was believed
that lineage-specifying transcription factors such as T-bet
and RORgt might be mutually exclusive in expression. T-bet
was not required for the differentiation or maintenance of
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CCR6/lo ILC3s to NKp46+CCR6/lo ILC3s (Klose et al., 2013;
Rankin et al., 2013). In addition, an increasing T-bet gradient in
CCR6/lo ILC3s directed a transcriptional program that allowed
for functional and phenotypic plasticity (Figure 1). For example,
T-bet controlled IFN-g production in NKp46+CCR6/lo ILC3s
that contributed to early immunity to Salmonella enterica infec-
tion. When inappropriately stimulated, NKp46+CCR6/lo ILC3s
contributed to intestinal inflammatory diseases in mice and hu-
mans (Bernink et al., 2013; Vonarbourg et al., 2010). T-bet
expression inCCR6/lo ILC3swas independent of IL-12 signaling
but was promoted by IL-23 (Klose et al., 2013), revealing an inter-
esting parallel to the signals driving plasticity of Th17 cells in a
mouse model of multiple sclerosis (Hirota et al., 2011).
Recent data revealed an important role for maternal vitamin A
metabolites in the differentiation and maintenance of fetal
CCR6+ ILC3 with LTi function. Mice deficient of retinoic acid re-
ceptor (RAR)a expression in hematopoietic cells had reduced
numbers of fetal CCR6+ ILC3s due to inefficient upregulation of
the Rorc(gt) transcript of the Rorc gene (van de Pavert et al.,
2014). Reduced ILC3 numbers led to the formation of substan-
tially smaller lymphoid organs, ultimately reducing the fitness
of adult mice to virus infections (van de Pavert et al., 2014).
Similar findings were reported for adult mice under conditions
of vitamin A malnutrition that presented with reduced numbers
of IL-22-producing ILC3s (Spencer et al., 2014). Vitamin A depra-
vation of adult mice led to impaired immunity to attaching-and-
effacing infections with C. rodentium. Whereas ILC3 numbers
and function were reduced under conditions of retinoic acid defi-
ciency, ILC2s were increased in a compensatory manner result-
ing in enhanced immunity to nematode infection (Spencer et al.,
2014). These data and the data from AhR-deficient mice estab-
lish an important trajectory by which nutrients instruct differenti-
ation and maintenance of mucosal ILC subsets.
Conclusions and Perspectives
The discovery of new ILC lineages has entirely redefined our
hematopoietic lineage maps (Figure 1). It is now clear that the
diversity of ILCs is much higher than previously appreciated.
The description of ILC-restricted progenitors (i.e., CHILP) has
now opened opportunities to examine the cues that drive differ-
entiation of the various helper-like ILC populations. While the
similarities between helper-like ILCs and T helper cell subsets
are striking, it is already clear that the cytokine signals required
for T helper fate decisions are dispensable for the differentiation
into the various helper-like ILC populations (Guo et al., 2014;
Klose et al., 2013; Liang et al., 2012). Thus, one of the important
future goals will be to identify the signals that drive differentiation
of the CHILP. Although a naive CD4 T cell can be differentiated
into any Th effector state depending on the cytokine environment
provided, it should be considered that ILC fate might be deter-
mined through a timed release of progenitors during ontogeny
into an environment that allows for the preferential differentiation
into a certain ILC fate. Precedent for such temporal organization
of lymphoid-fate decisions are the various waves of distinct gd
T cell subsets leaving the thymus before birth. Such future lines
of researchmight also reveal an evolutionary perspective on how
such transcriptional programs controlling lymphoid fate have
emerged. In addition, although ILC2s seem to be a relativelystable subset compared to ILC1s and ILC3s, there is still a
possibility of plasticity between ILC2s and other ILC subsets
(Crellin et al., 2010a; Spooner et al., 2013). Given the emerging
roles of transcriptional and functional plasticity of lymphocyte
subsets for the pathogenesis of inflammatory diseases (Hirota
et al., 2011; Vonarbourg et al., 2010), the molecular cues stabiliz-
ing ILC fates and those driving plasticity should be identified
because they might reveal therapeutic targets for such debili-
tating diseases. Thus, future research needs to identify the
signals and the spatiotemporal organization of helper-like ILC
development.
Research into ILC lineages has also revealed that the popula-
tion of NKp46+ cells, previously addressed as ‘‘NK cells,’’ is
more complex than appreciated. For example, the population of
NKp46+ cells in the lamina propria of the intestine is composed
of at least three distinct ILC populations (Klose et al., 2014). The
unique contributions of these various NKp46+ ILC subsets to
immune responses remain to be determined. In that context, it
is interesting to note that cNK cells might be a lineage distinct
from helper-like ILCs. It will be informative to position the branch-
ing point of the cytotoxic and helper-like ILC lineages on hemato-
poietic lineagemaps. Thiswill be complemented by analyzing the
core transcriptional programdetermining ILC fate. Id2hasalready
been discovered as one central hub for ILC fate and NFIL3 and
TOX might be other candidates. The DNA binding factor TOX is
an interesting candidate because Tox/ mice lack NK cell and
ILC3 development (Aliahmad et al., 2012; Geiger et al., 2014).
Finally, lymphoid cells use immune-recognition receptors for
development and to interact with infected or damaged cells. It
remains unclear whether immunoreceptors expressed by ILCs
are required for their function and/or development. Mice lacking
the Ncr1 gene and consequently not expressing NKp46 showed
normal development and function of ILC3s documented by their
resistance to C. rodentium infection (Satoh-Takayama et al.,
2009). Consecutive work documented a role for activating immu-
noreceptors for ILC function. Human ILC3s from tonsils and
colon could be activated for TNF release when triggered by the
NKp44 receptor (Glatzer et al., 2013). In mice, liver-resident
ILC1s responded to engagement of various activating immu-
noreceptors (i.e., NKp46, NKG2D, NK1.1) with the production
of TNF, IFN-g, and CCL3 (Daussy et al., 2014). Interestingly,
liver-resident ILC1s with an ‘‘NK cell phenotype’’ display anti-
gen-specific memory that does not require recombining recep-
tors (O’Leary et al., 2006; Paust et al., 2010). The phenotype of
such memory ‘‘NK cells’’ might indicate that they are an ILC1
subset. It will be highly informative to gain a more molecular
understanding of how ILCs discriminate between ‘‘self’’ and
‘‘non-self’’ and how previous activation might introduce a
memory-like program into innate lymphocytes.
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